Product Images Saphris

This is a description of a medication called "Assapine" which is distributed by Sehering-Plough Corp. in Kenilworth, NJ. The medication is distributed in sublingual tablet form and contains 10mg of Assapine maleate, as well as gelatin NF and mannitol USP. The lot number of the medication is 9821628 with a distribution date of August 11th. The NDC number is 16590093660 and the medication is only allowed to be used by the person for whom it was prescribed. Further information on the medication can be found in the package insert.*

This is a figure showing the Kaplan-Meier estimation of the percentage of relapse or impending relapse for SAPHRIS and placebo. The x-axis represents time in days, while the y-axis represents the percentage of relapse or impending relapse. The estimation is based on the Kaplan Meier distribution with censoring of the last double-blind dose date. Not available.*

This is an instruction manual for the administration of a tablet. It is advised not to remove the tablet pack until ready to administer and to use dry hands while handling the tablet. The tablet should not be pushed, cut, or torn while in the pack. First, press and hold the thumb button then pull out the tablet pack. Next, peel back the colored tab and gently remove the tablet. The tablet should be placed under the tongue and dissolves completely. It is not recommended to chew, swallow or crush the tablet. After administration, slide the tablet pack into the case until it clicks. Eating and drinking are not recommended for the next ten minutes.*